Bryan Wahl
2022
In 2022, Bryan Wahl earned a total compensation of $2.5M as General Counsel and Secretary at Tarsus Pharmaceuticals, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,000 |
|---|---|
| Option Awards | $880,641 |
| Salary | $420,000 |
| Stock Awards | $1,034,621 |
| Other | $31,087 |
| Total | $2,534,349 |
Wahl received $1M in stock awards, accounting for 41% of the total pay in 2022.
Wahl also received $168K in non-equity incentive plan, $880.6K in option awards, $420K in salary and $31.1K in other compensation.
Rankings
In 2022, Bryan Wahl's compensation ranked 1,428th out of 5,744 executives tracked by ExecPay. In other words, Wahl earned more than 75.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,428 out of 5,744 | 75th |
Division Manufacturing | 712 out of 3,128 | 77th |
Major group Chemicals And Allied Products | 275 out of 1,416 | 81st |
Industry group Drugs | 254 out of 1,317 | 81st |
Industry Biological Products, Except Diagnostic Substances | 67 out of 291 | 77th |
Source: SEC filing on April 26, 2023.
Wahl's colleagues
We found two more compensation records of executives who worked with Bryan Wahl at Tarsus Pharmaceuticals in 2022.